Atlas Trials

A Study to Compare the Pharmacokinetics of Different Oral Formulations of FDL169 in Healthy Subjects

Clinical trial NCT03527095 · COMPLETED

Trial details

NCT number
NCT03527095
Sponsor
Flatley Discovery Lab LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2018-04-05
Primary completion
2018-06-21
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.